Published on in Vol 8, No 1 (2022): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33311, first published .
Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study

Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study

Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study

Journals

  1. Kang D, Kim S, Kim H, Lee M, Kong S, Chang Y, Sim S, Kim Y, Cho J. Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study. JMIR Public Health and Surveillance 2023;9:e44105 View
  2. Sarker J, Carkovic E, Ptaszek K, Lee T. Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2024;44(5):383 View
  3. Golder S, O'Connor K, Wang Y, Klein A, Gonzalez Hernandez G. The value of social media analysis for adverse events detection and pharmacovigilance: a Scoping Review (Preprint). JMIR Public Health and Surveillance 2024 View